Background {#Sec1}
==========

Periodontitis is a chronic inflammatory disease involving interactions between complex microbial biofilms, many cell populations and inflammatory mediators, leading to the destruction of the tooth-supporting structures like the periodontal ligament and the alveolar bone \[[@CR1]\]. Besides being a common cause of tooth loss, severe periodontitis (about 8.5 % of patients) can detrimentally affect systemic health, as it can increase the patients' risk for diabetes, atherosclerosis, rheumatoid arthritis, and adverse pregnancy outcomes \[[@CR2]--[@CR4]\]. Two major clinical entities of periodontitis are currently recognized: chronic periodontitis, which is more common, and aggressive periodontitis, a clinically challenging entity featured by an early onset and a rapid progression \[[@CR5]\]. The underlying etiology of both the two forms has not been fully elucidated. Therefore, gaining further insights into the molecular mechanisms of periodontitis will be of great significance for the treatment of periodontitis.

Previous studies have demonstrated that factors that may determine the presence and rate of progression of periodontitis are complex, which can be defined as the interplay of numerous parameters acting simultaneously and unpredictably \[[@CR1]\]. For instance, the tooth-associated microbial biofilm or dental plaque is essential but not sufficient to induce periodontitis. The host inflammatory response to the microbial challenge can finally cause the destruction of the periodontium \[[@CR6]\]. Inflammation and bone loss are hallmarks of periodontal disease \[[@CR7]\] and accumulated evidence demonstrates that a number of mediators are involved in these processes \[[@CR8]\]. Cochran et al. had reported that the reduction of inflammation and attenuation of the host's immune reaction to the microbial plaque could lead to a decrease in the ratio of nuclear factor-kappa B ligand (RANKL)/osteoprotegerin (OPG) and a decrease in associated bone loss \[[@CR7]\]. Besides, a study has reviewed that cytokines such as interleukin-1 (IL-1) and tumor necrosis factor (TNF) are a significant and integral component of the host reaction to periodontal infection \[[@CR8]\]. In addition, secreted IL-8 induced by multiple stimuli like live bacteria and proinflammatory cytokines is associated with the inflammation and invasiveness of periodontitis \[[@CR9]\]. Despite of numerous investigations on periodontitis, the mechanism still remains largely unknown.

Using the same gene expression profile, Stoecklin et al. identified specific miRNAs (has-miR-210 and hsa-miR-185) and their target genes in gingival tissues \[[@CR10]\]. In addition, Kebschull et al. found that small differences in gene expression and the highly variable classifier performance suggested limited dissimilarities between established chronic periodontitis and aggressive periodontitis lesions \[[@CR11]\]. We sought to have an expression profiling comparison between periodontitis (chronic periodontitis and aggressive periodontitis collectively) and normal control, identifying more candidate genes involved in both chronic and aggressive periodontitis and to gain more insights into the molecular mechanisms of periodontitis progression.

Methods {#Sec2}
=======

Microarray data and data preprocessing {#Sec3}
--------------------------------------

The gene expression profile data of GSE16134 \[[@CR11]\] was downloaded from the Gene Expression Omnibus (GEO) in NCBI (<http://www.ncbi.nlm.nih.gov/geo/>) based on the platform of GPL570 \[HG-U133_Plus_2\] Affymetrix Human Genome U133 Plus 2.0 Array. This dataset included 241 'diseased' gingival tissue specimens (bleeding on probing, probing depth ≥ 4 mm, and clinical attachment loss ≥ 3 mm) and 69 'healthy' gingival tissue samples (no bleeding on probing, probing depth ≤ 4 mm, and clinical attachment loss ≤ 4 mm), obtained from 120 systemically healthy, non-smoking individuals with moderate/severe periodontitis (65 with chronic and 55 with aggressive periodontitis), as previously described \[[@CR11], [@CR12]\]. The 120 patients undergoing periodontal surgery contributed with a minimum of two interproximal gingival papillae from a maxillary posterior and when available, a 'healthy' papilla was obtained. In the present study, samples from chronic and aggressive periodontitis patients were taken together as one group, designed as periodontitis samples, and were compared with the 69 'healthy' gingival tissue samples as controls in the following analysis.

The downloaded profile had been preprocessed which was carried out with background correction, log~2~ transformation, and quantile normalization using the RMA (Robust Multi-array Analysis) method of affy package in R \[[@CR13]\]. In this study, those probes hybridizing to the same gene were normalized using the preprocessCore package \[[@CR14]\]. The gene expression matrix of specimens was received and was used to the follow-up analysis.

Screening of DEGs {#Sec4}
-----------------

The DEGs in periodontitis samples were screened compared with control samples using the Linear Models for Microarray data (limma) package in R \[[@CR15]\]. False discovery rate (FDR) \[[@CR16]\] was applied for multiple testing correction using Benjamini and Hochberg method \[[@CR17]\]. Threshold for the DEGs were set as FDR \< 0.05 and \|log~2~ FC (fold change)\| ≥ 0.58.

Function and pathway enrichment analysis of DEGs {#Sec5}
------------------------------------------------

In order to investigate the periodontitis progression on the perspective of functional level, Gene Ontology (GO) and pathway enrichment analysis of the identified DEGs were performed in this study. GO categories such as biological process (BP), molecular function (MF), and cellular component (CC) upon the identified DEGs were enriched from GO databases using the Hypergeometric Distribution test \[[@CR18]\]. Also, the pathways that the DEGs involved in were enriched using the Hypergeometric Distribution test from the KEGG (Kyoto Encyclopedia of Genes and Genomes) database \[[@CR19]\], which had not been used by Kebschull et al. \[[@CR12]\]. The p-value \< 0.05 was chosen as the threshold.

PPI network construction of DEGs and modules selection {#Sec6}
------------------------------------------------------

The STRING (Search Tool for the Retrieval of Interacting Genes/Proteins) database, which is a database of known and predicted protein interactions \[[@CR20]\], was used to select the interactions among the selected DEGs in this study, which were not used in the study of Kebschull et al. \[[@CR12]\]. The PPI network was constructed by functional links between proteins that are experimentally derived, as well as links predicted by co-expression analysis and text mining, or PPIs which had related records in the database. Genes included in the PPI network were all DEGs. Besides, the combined score ≥ 0.4 were chosen for the PPI network construction. Cytoscape software \[[@CR21]\] was used to visualize the constructed network while MCODE \[[@CR22]\] was used to select significant modules from the PPI network (Parameters: Degree cutoff: 2, Node score cutoff: 0.2, K-core: 2, Max. depth: 100). Furthermore, topological analysis of the PPI network was performed and node degrees of these DEGs were analyzed.

Function annotation of the DEGs and construction of regulatory network {#Sec7}
----------------------------------------------------------------------

To identify the DEGs which had the transcriptional regulatory functions, the identified DEGs in this study were analyzed using the TRANSFAC database (<http://www.gene-regulation.com/pub/databases.html>) \[[@CR23]\], a database comprising data of transcription factors (TFs), their target genes and regulatory binding sites. Moreover, a regulatory network based on the identified TFs and their target DEGs was constructed. While in the study of Kebschull et al. \[[@CR12]\], TRANSFAC database had not been used.

Results {#Sec8}
=======

Data preprocessing and DEGs screening {#Sec9}
-------------------------------------

In the original analysis of Kebschull et al. \[[@CR12]\], a total of 248 differentially regulated probes were identified at an absolute fold change of ≥1.19, and 30 overexpressed only one under-expressed probe by an absolute change of \>1.5 fold were identified in aggressive periodontitis lesions compared with chronic periodontitis lesions. However, in this study, after data preprocessing, 20,303 genes were mapped to the probes. Compared with the control samples, a total of 762 DEGs were identified in the periodontitis samples (Additional file [1](#MOESM1){ref-type="media"}: Table S1), including 507 up-regulated genes and 255 down-regulated genes.

GO and pathway enrichment analysis of DEGs {#Sec10}
------------------------------------------

Functional and pathway enrichment analysis indicated that up-regulated DEGs and down-regulated DEGs in the periodontitis samples were significantly enriched in different GO terms and KEGG pathways (Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"}). Top 5 GO terms of up- and down-regulated genes were shown in Table [1](#Tab1){ref-type="table"}, respectively. The up-regulated genes were involved in different GO terms such as cell activation, activation of immune response, chemokine activity, and antigen binding (Table [1A](#Tab1){ref-type="table"}). While the down-regulated genes were associated with the GO terms like skin development, epidermal cell differentiation, intermediate filament, and structural molecule activity (Table [1B](#Tab1){ref-type="table"}). On the other hand, top 10 pathways of up- and down-regulated genes were shown in Table [2](#Tab2){ref-type="table"}, respectively. The pathway enrichment analysis showed that the up-regulated genes were mainly involved in staphylococcus aureus infection and cytokine-cytokine receptor interaction (Table [2A](#Tab2){ref-type="table"}), while the down-regulate genes were mainly associated with the pathways such as metabolic pathways, phagosome, and melanogenesis pathways (Table [2B](#Tab2){ref-type="table"}).Table 1The functional analysis of the DEGsCategoryGO IDNameCount*p*-valueA: the top 5 GO terms of the up-regulated DEGsBPGO:0001775cell activation68\<1.00E-16BPGO:0002253activation of immune response48\<1.00E-16BPGO:0002376immune system process165\<1.00E-16BPGO:0002682regulation of immune system process94\<1.00E-16BPGO:0002684positive regulation of immune system process73\<1.00E-16CCGO:0005576extracellular region138\<1.00E-16CCGO:0005615extracellular space70\<1.00E-16CCGO:0044421extracellular region part86\<1.00E-16CCGO:0071944cell periphery1912.64E-14CCGO:0005886plasma membrane1861.49E-13MFGO:0008009chemokine activity102.35E-07MFGO:0003823antigen binding124.64E-07MFGO:0032403protein complex binding264.85E-07MFGO:0042379chemokine receptor binding101.11E-06MFGO:0005178integrin binding121.41E-06B: the top 5 GO terms of the down-regulated DEGsBPGO:0043588skin development3112.33E-14BPGO:0008544epidermis development2801.18E-12BPGO:0030216keratinocyte differentiation1081.09E-09BPGO:0009913epidermal cell differentiation1541.01E-08BPGO:0009888tissue development14792.09E-08CCGO:0030057desmosome225.73E-06CCGO:0005882intermediate filament1912.33E-05CCGO:0045111intermediate filament cytoskeleton2312.76E-05CCGO:0045095keratin filament930.00096928CCGO:0005911cell-cell junction2970.00108577MFGO:0005198structural molecule activity6272.89E-05MFGO:0005200structural constituent of cytoskeleton940.00104197MFGO:0016755transferase activity, transferring amino-acyl groups240.003031659MFGO:0016702oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen250.003414279MFGO:0016701oxidoreductase activity, acting on single donors with incorporation of molecular oxygen260.003825148*MF* molecular function, *BP* biological process, *CC* cell componentTable 2The pathway enrichment analysis of the DEGsKEGG IDNameCount*p*-valueA: the top 10 enriched pathways of the up-regulated DEGs5150Staphylococcus aureus infection554.40E-125144Malaria512.12E-094060Cytokine-cytokine receptor interaction2652.39E-084141Protein processing in endoplasmic reticulum1655.11E-074640Hematopoietic cell lineage885.53E-075323Rheumatoid arthritis918.66E-075140Leishmaniasis721.64E-064670Leukocyte transendothelial migration1164.30E-064514Cell adhesion molecules (CAMs)1336.18E-064062Chemokine signaling pathway1891.71E-05B: the top 10 enriched pathways of the down-regulated DEGs590Arachidonic acid metabolism590.002776062980Metabolism of xenobiotics by cytochrome P450710.005420335982Drug metabolism - cytochrome P450730.005982341350Tyrosine metabolism410.0078422481100Metabolic pathways11300.0121028475144Malaria510.0142743115014Amyotrophic lateral sclerosis (ALS)530.0158321674145Phagosome1530.0182152474916Melanogenesis1010.018240082563Glycosylphosphatidylinositol (GPI)-anchor biosynthesis250.025692313830Retinol metabolism640.026060907591Linoleic acid metabolism300.036083866

PPI network construction and modules selection {#Sec11}
----------------------------------------------

The PPI network upon the DEGs was shown in Fig. [1](#Fig1){ref-type="fig"}. The results of topological analysis showed that interleukin-6 (*IL-6*), cathepsin S (*CTSS*), and pleckstrin (*PLEK*) were the hub proteins in the PPI network which had higher node degrees (Fig. [2a](#Fig2){ref-type="fig"}). In addition, 3 significant modules were selected from the PPI network (Fig. [2](#Fig2){ref-type="fig"}). From the results, we found that most of the genes enriched in the 3 modules were up-regulated. In particular, the top 5 genes with higher node degrees in module 1 were *CTSS* (degree = 20), chemokine (C-C motif) ligand 5 (*CCL5)* (degree = 19), *PLEK* (degree = 19), chemokine (C-C motif) receptor 1 (*CCR1*) (degree=19), and formyl peptide receptor 1 (*FPR1*) (degree=19) (Fig. [2b](#Fig2){ref-type="fig"}, Table [3](#Tab3){ref-type="table"}). The top 5 genes with higher node degrees in module 2 were *IL6* (degree = 17), lymphocyte-specific protein tyrosine kinase (*LCK*) (degree = 14), Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide (*FCER1G*) (degree = 13), *CD19* (degree = 13), and colony stimulating factor 1 receptor (*CSF1R*) (degree = 13) (Fig. [2c](#Fig2){ref-type="fig"}, Table [3](#Tab3){ref-type="table"}). Additionally, the top 5 genes with higher node degrees in module 3 were *IL8* (degree = 13), *IL1B* (degree = 12), *MMP9* (degree = 11), prostaglandin-endoperoxide synthase 2 (*PTGS2*) (degree=11), and plasminogen activator, tissue (*PLAT*) (degree=10) (Fig. [2d](#Fig2){ref-type="fig"}, Table [3](#Tab3){ref-type="table"}).Fig. 1Protein-protein interaction (PPI) network of the differentially expressed genes (DEGs). Red nodes stand for the up-regulated DEGs while green nodes stand for the down-regulated genesFig. 2Analysis of the PPI network.A, topological analysis of the degrees of the DEGs in the PPI network. Horizontal axis stands for the degree of one DEG and vertical axis stands for the number of nodes. B, module 1 of DEGs from PPI network. C, module 2 of DEGs from PPI network. D, module 3 of DEGs from PPI network. Red nodes stand for the up-regulated DEGs while green nodes stand for the down-regulated genes. The size of one node is proportional to the degree of this geneTable 3The top 5 DEGs with higher degrees in the selected modulesModuleGeneExpression changesDegreemodule 1CTSSup20CCL5up19PLEKup19CCR1up19FPR1up19Module 2IL6up17LCKup14FCER1Gup13CD19up13CSF1Rup13Module 3IL8up13IL1Bup12MMP9up11PTGS2up11PLATup10

Regulatory network construction {#Sec12}
-------------------------------

A total of 9 TFs were identified from the up-regulated DEGs, such as interferon regulatory factor 4 (IRF4), IRF8, and FBJ murine osteosarcoma viral oncogene homolog B (FOSB). Besides, 10 TFs from the down-regulated DEGs were selected, such as Kruppel-like factor 4 (KLF4), v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog (MAF), and Meis homeobox 1 (MEIS1). The regulatory network of these TFs and their target genes was shown in Fig. [3](#Fig3){ref-type="fig"}. From the results, we found that several DEGs with higher degrees in module 1 could be regulated by IRF8, for example, *CTSS*, *CCL5*, and *PLEK*.Fig. 3Regulatory network of the transcription factors-DEGs. Diamond represents the transcription factor while the circle represents the DEG. Red color stands for up-regulated expression while green color stands for down-regulated expression

Discussion {#Sec13}
==========

In this study, we used the microarray data to select genes associated with periodontitis. Totally, 762 DEGs in the periodontitis samples were identified compared with the control samples. The up-regulated genes were mainly enriched in the GO terms like cell activation and activation of immune response, as well as the pathways such as staphylococcus aureus infection and cytokine-cytokine receptor interaction. The down-regulated genes were mainly linked to tissue development and metabolism pathways. *CTSS*, *PLEK*, *LCK*, and *PTGS2* were identified to be hub proteins in the PPI network or in the selected module. Besides, 9 TFs and 10 TFs were selected from the up-regulated genes and down-regulated genes respectively, for example, IRF4, IRF8, and FOSB.

Our results showed that 20,303 genes were mapped to the probes. Compared with the healthy samples, a total of 762 DEGs were identified in the periodontitis samples, including 507 up-regulated genes (FDR\< 0.05 and log~2~ FC ≥ 0.58) and 255 down-regulated genes (FDR\< 0.05 and log~2~ FC \< −0.58). While, Kebschull et al. identified a total of 248 differentially regulated probes at an absolute fold change of ≥1.19 \[[@CR12]\]. They reported 30 overexpressed and only one under-expressed probe by an absolute change of \>1.5 fold in aggressive periodontitis lesions compared with chronic periodontitis lesions. Besides, they found that 9258 probes were differentially expressed when compared the 'diseased' tissues with 'healthy' gingival tissues. Collectively, the results showed that we identified distinct genetic features in periodontitis samples using different screening methods with different thresholds.

In this study, we found that DEGs in periodontitis samples were mainly enriched in different GO terms and pathways, such as cell activation, activation of immune response, staphylococcus aureus infection and cytokine-cytokine receptor interaction, using KEGG database which were not used by Kebschull et al. \[[@CR12]\]. In their investigations, gene set enrichment analysis was performed and gene sets linked to apoptosis, immune response were enriched in aggressive periodontitis lesions, while genes sets linked to cellular metabolism and epithelial integrity were enriched in chronic periodontitis lesions \[[@CR12]\]. In a susceptible host, persistence of bacteria pathogens such as *Porphyromonas gingivalis* results in aberrant and extended inflammation and subsequent destruction of the tooth-supporting structures \[[@CR24]\]. The immune cells such as antigen presenting cells (APC) initially responding to the challenge by bacteria pathogens, including *Porphyromonas gingivalis*, poised strategically along portals of entry \[[@CR25]\]. After recognition of pathogen associated molecular patterns (PAMPs) via pattern recognition receptors (eg, toll like receptors \[TLRs\]), innate immune cells start responses aiming to clear the inciting agent \[[@CR26]\]. Moutsopoulos et al. had showed that *Porphyromonas gingivalis* could promote T helper cell 17 (Th17) inducing pathways in chronic periodontitis \[[@CR24]\]. Thus, the enrichment results identified in our study was in accordance with the previous studies.

CTSS is a lysosomal cysteine proteinase that may participate in the degradation of antigenic proteins to peptides for presentation on MHC class II molecules \[[@CR27]\]. Deficiency of CTSS induces a high bone turnover and then leading to the less dense bone \[[@CR28]\]. Mogi et al. demonstrated that the expression level of the key bone degradation enzyme cathepsin K (another member of family proteins) in gingival crevicular fluid tissues of periodontitis patients was higher than that in normal tissues \[[@CR29]\]. Besides, IRF8 can specifically bind to the upstream regulatory region of type I interferon (IFN). Zhao et al. had demonstrated that IRF-8 was a regulator for osteoclastogenesis in bone metabolism \[[@CR30]\]. Soft tissue destruction and bone degradation were often found in periodontitis \[[@CR31]\]. Moreover, a study revealed that CTSS had the binding site for transcription factor IRF1, and combination of IRF8 and IRF1 could promote the CTSS expression \[[@CR32]\]. In the present study, CTSS was a hub protein in the PPI network and could be regulate by IRF8 in the regulatory network. In the context, we suggested that *CTSS* might play an essential role in bone loss involved in periodontitis progression by interacting with *IRF8*.

On the other hand, PLEK is a major substrate of protein kinase C in platelets and leukocytes and appears to play an important role in exocytosis through a currently unknown mechanism \[[@CR33]\]. Ding et al. proved that the phosphorylated PLEK increased the secretion of proinflammatory cytokine in mononuclear phagocytes \[[@CR34]\]. Besides, Ueki et al. had showed that the secreted monocytes activated by bacterial in gingival crevicular fluid was associated with periodontitis \[[@CR35]\]. On the other hand, IRF8 can specifically bind to the upstream regulatory region of IFN \[[@CR36]\]. Additionally, Bar-Or et al. showed that B cells could exhibit abnormal proinflammatory cytokine responses (such as exaggerated production of TNF) when activated in the context of the Th1 cytokine IFN \[[@CR37]\]. In this study, the results showed that *PLEK* was a hub protein in the PPI network and could be regulated by IRF8 in the regulatory network. Therefore, we speculated that *PLEK* might contribute to the periodontitis progression via interacting with *IRF-8*.

PTGS2 is an isozyme of PTGS which is the key enzyme in prostaglandin biosynthesis, and acts both as a dioxygenase and as a peroxidase \[[@CR38]\]. The study of Zhang et al. had demonstrated that there was a hypermethylation pattern of the promoter in connection with a lower level of PTGS2 transcription in the inflamed tissues in chronic periodontitis \[[@CR39]\]. On the other hand, FOSB is one member of the Fos gene family which encodes leucine zipper proteins that can dimerize with proteins of the JUN family \[[@CR40]\]. T cell receptor (TCR)-driven early gene expression is controlled by numerous key transcription factors such as FOSB \[[@CR41]\]. Additionally, Sreeramkumar et al. had reported that PTGS2 was transcriptionally up-regulated in T cells during TCR/CD3 triggering and that it behaved as an early inducible gene in the T cell activation process \[[@CR42]\]. Moreover, Chen et al. had demonstrated that costimulatory double signals from CD28 and TCR were required for optimal expression of receptor activator of nuclear factor-κB ligand (RANKL) in periodontal tissues \[[@CR43]\]. In the present study, the results showed that *PTGS2* was involved in module 3 and could be regulated by FOSB in the regulatory network. Thus, we suggested that *PTGS2* might play a critical role in periodontitis progression involving in TCR signaling pathway via interacting with *FOSB.*

Conclusion {#Sec14}
==========

In conclusion, this study identified several genes (*CTSS*, *PLEK*, *IRF-8*, *PTGS2* and FOSB) that involved in the development and progression of periodontitis. *CTSS* may play an essential role in bone loss associated with periodontitis by interacting with *IRF8.* Besides, *PLEK* may contribute to the periodontitis progression via interacting with *IRF-8*. In addition, *PTGS2* may play a critical role in periodontitis progression involving in TCR signaling pathway via interacting with *FOSB.* Our study may provide theoretical basis for the future investigations of periodontitis. However, further experimental studies are still needed to confirm our results.

Additional file {#Sec15}
===============

Additional file 1: Table S1.All the differentially expressed genes (DEGs) in periodontitis samples with their corresponding modules (DOCX 102 kb)

APC

:   Antigen presenting cells

BP

:   Biological processes, CTSS, Cathepsin S, CC, Cellular component

DEGs

:   Differentially expressed genes, IRF4, Factor 4, FDR, False discovery rate, GO, Gene Ontology

IL-6

:   Interleukin-6

IL-8

:   Interleukin-8, KEGG, Kyoto Encyclopedia of Genes and Genomes

KLF4

:   Kruppel-like factor 4

MMP

:   Matrix metalloproteinase, MEIS1, Meis homeobox 1
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:   Molecular functions
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:   Pathogen associated molecular patterns

PPI
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